Royalty Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:RPD Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
04 Jan 24	Sell€12,065,861	Rory Riggs	Individual	470,000	€26.02
29 Dec 23	Sell€1,669,538	Mario Giuliani	Individual	65,803	€25.37
28 Dec 23	Sell€6,398,765	Mario Giuliani	Individual	251,592	€25.46

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RPD?
Owner Type	Number of Shares	Ownership Percentage
State or Government	182,926	0.0412%
Individual Insiders	60,199,824	13.5%
General Public	62,839,066	14.1%
Institutions	321,079,845	72.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 65.01% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11.7%	Mario Giuliani	51,981,509	€1.6b	-3.69%	no data
8.46%	The Vanguard Group, Inc.	37,585,123	€1.2b	-1.15%	0.01%
7.56%	Morgan Stanley Investment Management Inc.	33,577,693	€1.1b	-7.53%	0.64%
5.07%	FMR LLC	22,529,209	€713.5m	-5.72%	0.03%
5.02%	BlackRock, Inc.	22,301,159	€706.3m	-3.11%	0.01%
3.63%	Baillie Gifford & Co.	16,122,491	€510.6m	-1.41%	0.17%
2.72%	Viking Global Investors LP	12,094,021	€383.0m	1.04%	1.03%
2.68%	Adage Capital Management, L.P.	11,899,194	€376.9m	8.85%	0.51%
2.48%	Swedbank Robur Fonder AB	11,027,370	€349.3m	1.98%	0.18%
2.14%	State Street Global Advisors, Inc.	9,516,262	€301.4m	0.31%	0.01%
1.64%	Geode Capital Management, LLC	7,265,786	€230.1m	6.1%	0.01%
1.21%	Strategic Advisers LLC	5,360,934	€169.8m	34.3%	0.05%
1.12%	Morgan Stanley, Investment Banking and Brokerage Investments	4,975,652	€157.6m	-3.15%	0.01%
1.08%	Norges Bank Investment Management	4,809,343	€152.3m	0%	0.01%
1.07%	Millennium Management LLC	4,750,030	€150.4m	71.6%	0.1%
1.03%	UBS Asset Management AG	4,589,686	€145.4m	12.4%	0.01%
0.83%	Amundi Asset Management SAS	3,691,255	€116.9m	78.8%	0.02%
0.83%	Pablo Legorreta	3,668,170	€116.2m	0%	no data
0.76%	Siguler Guff & Company, LP	3,391,754	€107.4m	0%	36.44%
0.7%	Legal & General Investment Management Limited	3,112,561	€98.6m	1.06%	0.01%
0.7%	GMT Capital Corp.	3,097,500	€98.1m	27.6%	2.35%
0.68%	Two Sigma Advisers, LP	3,033,200	€96.1m	44.7%	0.17%
0.68%	Charles Schwab Investment Management, Inc.	3,001,603	€95.1m	58.1%	0.01%
0.66%	Northern Trust Global Investments	2,953,810	€93.6m	-10.4%	0.01%
0.56%	Eaton Vance Management	2,502,662	€79.3m	-6.05%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 09:03
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Royalty Pharma plc is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Ishan Majumdar	Baptista Research
Charlie Yang	BofA Global Research
Jason Matthew Gerberry	BofA Global Research